Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Strauss, Julius
384  Ergebnisse:
Personensuche X
?
1

A deep-learning framework to predict cancer treatment respo..:

Hoang, Danh-Tai ; Dinstag, Gal ; Shulman, Eldad D....
Nature Cancer.  , 2024
Link: https://doi.org/10.1038/..
 
?
2

First-in-human phase Ib trial of M9241 (NHS-IL12) plus avel..:

Strauss, Julius ; Deville, Jean-Laurent ; Sznol, Mario...
Journal for ImmunoTherapy of Cancer.  11 (2023)  5 - p. e005813 , 2023
Link: https://doi.org/10.1136/..
 
?
3

Immune correlates with response in patients with metastatic..:

Toney, Nicole J. ; Gatti-Mays, Margaret E. ; Tschernia, Nicholas P....
International Immunopharmacology.  116 (2023)  - p. 109736 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Effect of CD4+ T cell count on treatment-emergent adverse e..:

Odeny, Thomas A ; Lurain, Kathryn ; Strauss, Julius...
Journal for ImmunoTherapy of Cancer.  10 (2022)  9 - p. e005128 , 2022
Link: https://doi.org/10.1136/..
 
?
5

Immune correlates of clinical parameters in patients with H..:

Tsai, Yo-Ting ; Strauss, Julius ; Toney, Nicole J...
Journal for ImmunoTherapy of Cancer.  10 (2022)  4 - p. e004601 , 2022
Link: https://doi.org/10.1136/..
 
?
6

Concomitant Medication Effects on Immune Checkpoint Inhibit..:

Sieber, Brendan ; Strauss, Julius ; Li, Zihai.
Frontiers in Oncology.  12 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
7

Non-synergy of PD-1 blockade with T-cell therapy in solid t..:

Davies, John S ; Karimipour, Farrah ; Zhang, Ling...
Journal for ImmunoTherapy of Cancer.  10 (2022)  7 - p. e004906 , 2022
Link: https://doi.org/10.1136/..
 
?
8

Randomized, Double-Blind, Placebo-Controlled Phase II Study..:

DeMaria, Peter Joseph ; Bilusic, Marijo ; Park, Deric M....
The Oncologist.  26 (2021)  5 - p. e847-e858 , 2021
Link: https://doi.org/10.1002/..
 
?
9

Phase 1 open-label trial of intravenous administration of M..:

DeMaria, Peter J ; Lee-Wisdom, Katherine ; Donahue, Renee N...
Journal for ImmunoTherapy of Cancer.  9 (2021)  9 - p. e003238 , 2021
Link: https://doi.org/10.1136/..
 
?
10

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/..:

Bilusic, Marijo ; McMahon, Sheri ; Madan, Ravi A...
Journal for ImmunoTherapy of Cancer.  9 (2021)  3 - p. e002374 , 2021
Link: https://doi.org/10.1136/..
 
?
11

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-P..:

Lind, Hanne ; Gameiro, Sofia R ; Jochems, Caroline...
Journal for ImmunoTherapy of Cancer.  8 (2020)  1 - p. e000433 , 2020
Link: https://doi.org/10.1136/..
 
?
12

14937 Keratoacanthomas associated with anti–TGF-β immunothe..:

Wang, Catherine J. ; Lamping, Elizabeth ; Strauss, Julius.
Journal of the American Academy of Dermatology.  83 (2020)  6 - p. AB24 , 2020
Link: https://doi.org/10.1016/..
 
?
13

Bintrafusp alfa, a bifunctional fusion protein targeting TG..:

Strauss, Julius ; Gatti-Mays, Margaret E ; Cho, Byoung Chul...
Journal for ImmunoTherapy of Cancer.  8 (2020)  2 - p. e001395 , 2020
Link: https://doi.org/10.1136/..
 
?
14

Diffuse lichen planus-like keratoses and clinical pseudo-pr..:

Cardis, Michael A. ; Jiang, Hong ; Strauss, Julius..
BMC Cancer.  19 (2019)  1 - p. , 2019
Link: https://doi.org/10.1186/..
 
?
15

A Phase I Trial Using a Multitargeted Recombinant Adenoviru..:

Gatti-Mays, Margaret E. ; Redman, Jason M. ; Donahue, Renee N....
The Oncologist.  25 (2019)  6 - p. 479-e899 , 2019
Link: https://doi.org/10.1634/..
 
1-15